Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Bristol-Myers’ Sprycel to treat children with Ph+ ALL

pharmaceutical-technologyJanuary 04, 2019

Tag: FDA , Bristol-Myers , Sprycel , Ph+ ALL

PharmaSources Customer Service